Cell and gene manufacturing: a case study approach to overcoming challenges
Cell & Gene Therapy Insights 2021; 7(3), 393
Published: 29 April 2021
As cell therapy manufacturing moves from translational research to industrial scale-out, Sexton Biotechnologies spoke to competitors, customers, and collaborators to better understand the current challenges.
Watch the video or read the poster to learn:
- What are the biggest hurdles for cell and gene therapies?
- What are the challenges with current technologies and manufacturing methods?
- What are the biggest payoffs of solving these problems?